PHARMA MAR, S.A. 19/10/2018 08:11 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks 300 patients have been already recruited in the Phase III clinical trial HELIX for the treatment of the signs and symptoms of dry eye disease. Número de registro: 270622